Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AGN 201781 for neuropathic pain (postherpetic and post-traumatic) – pilot Phase 2 trial
2007-003787-21Phase 2Terminated
- Sponsor
- Allergan
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in postherpetic neuralgia (PHN) and Peripheral neuropathy comparing AGN 201781 with Placebo (2 arms). Primary endpoint: Daily-average pain score. Started Aug 2007; status: terminated.
02
Drugs
AGN201781
03
Conditions
postherpetic neuralgia (PHN)Peripheral neuropathy
Beyond the preview
Go deeper on 2007-003787-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003787-21.